p53 peptide vaccine

p53 peptide vaccine information and resources from the National Cancer Institute

p53 peptide vaccine

A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. p53 peptide vaccine

A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein.

p53 peptide vaccine -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org